Delivery Order SPE2DB20D7061-SPE2DB24FSPA1
Award Date
7/11/24
Potential Completion Date
7/12/24
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ELIQUIS 2.5 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,922.08, is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of ELIQUIS 2.5 MG TABLET 60S to the Defense Logistics Agency (DLA). The $1,900.08 Firm Fixed Price contract is a Delivery Order awarded under Amerisourcebergen's existing single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
The Defense Logistics Agency (DLA) awarded a $5,700.24 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide ELIQUIS 2.5 MG TABLET 60S. This order is part of a larger single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides the delivery of ELIQUIS 2.5 MG TABLET 60S to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price delivery order, valued at $2,137.59, has an ultimate completion date of April 11, 2024. This award is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded by DLA, which serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $11,645.01 Firm Fixed Price Delivery Order to provide ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA), a major Defense agency. The award has no set-aside designation and is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with the DLA through 2025 to supply a wide range of pharmaceutical products and medical supplies to the...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $22,069.93 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the procurement of ELIQUIS 5 MG TABLET 60S. The contract has an ultimate completion date of January 27, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of ELIQUIS 5 MG TABLET 60S to the Defense Logistics Agency (DLA) Troop Support Medical. The $28,172.23 firm fixed-price delivery order contract has an ultimate completion date of December 9, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award to Amerisourcebergen Drug Corp provides $8,456.36 for the delivery of ELIQUIS 2.5 MG TABLET 60S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 26, 2023. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a comprehensive...
This federal contract award is for a Delivery Order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide ELIQUIS 2.5 MG TABLET 60S. The contract has a firm fixed price ceiling value of $1,900.08 and an ultimate completion date of July 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $2,770.95 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ELIQUIS 2.5 MG TABLET 60S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the...